Watson Pharmaceuticals has promoted Todd Joyce as senior vice president and chief financial officer (CFO). He succeeds Mark Durand, who has departed as CFO for personal reasons, after standing in as acting principal financial officer since July.
Joyce joined Watson in 1997 as corporate controller, and was named vice president, corporate controller and treasurer in 2001. During the period of October 2006 to November 2007, he served as interim principal financial officer. He joined Watson from ICN Pharmaceuticals, where he served as vice president of tax from 1992-1996 and vice president of tax and finance from 1996 until 1997. Prior to ICN, Joyce served as a certified public accountant (CPA) for Coopers & Lybrand and Price Waterhouse.
Joyce has a BS in Business Administration from University of North Carolina and a MS in Taxation from Golden Gate University.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.